OncoMed Pharma (OMED) Reports Q4 Loss Per Share of $1.50

OncoMed Pharma (NASDAQ: OMED) reported Q4 EPS of ($1.50), versus ($0.63) reported last year. Revenue for the quarter came in at $6.84 million, versus $8.5 million reported last year.

For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.

You May Also Be Interested In

• Nike (NKE) Tops Q1 EPS by 4c
• Evercore ISI Downgrades Siemens AG (SIE:GR) (SIEGY) to In Line
• Barclays Upgrades Universal Music Group NV (UMG:NA) (UMGNF) to Overweight